Kruis W - Search Results

1

Development of strain-specific PCR reactions for the detection of the probiotic Escherichia coli strain Nissle 1917 in fecal samples.

Blum-Oehler G, Oswald S, Eiteljörge K, Sonnenborn U, Schulze J, Kruis W, Hacker J. Blum-Oehler G, et al. Among authors: kruis w. Res Microbiol. 2003 Jan-Feb;154(1):59-66. doi: 10.1016/s0923-2508(02)00007-4. Res Microbiol. 2003. PMID: 12576161 Free article.

2

Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine.

Kruis W, Fric P, Pokrotnieks J, Lukás M, Fixa B, Kascák M, Kamm MA, Weismueller J, Beglinger C, Stolte M, Wolff C, Schulze J. Kruis W, et al. Gut. 2004 Nov;53(11):1617-23. doi: 10.1136/gut.2003.037747. Gut. 2004. PMID: 15479682 Free PMC article. Clinical Trial.

3

Molecular biology in diagnosis and epidemiology of Helicobacter pylori: PCR for the detection and AP-PCR for characterization of patient isolates.

Schwarz E, Plum G, Mauff G, Hasbach H, Eidt S, Schrappe M, Kruis W. Schwarz E, et al. Among authors: kruis w. Zentralbl Bakteriol. 1997 Feb;285(3):368-78. doi: 10.1016/s0934-8840(97)80003-5. Zentralbl Bakteriol. 1997. PMID: 9084110

4

Low dose balsalazide (1.5 g twice daily) and mesalazine (0.5 g three times daily) maintained remission of ulcerative colitis but high dose balsalazide (3.0 g twice daily) was superior in preventing relapses.

Kruis W, Schreiber S, Theuer D, Brandes JW, Schütz E, Howaldt S, Krakamp B, Hämling J, Mönnikes H, Koop I, Stolte M, Pallant D, Ewald U. Kruis W, et al. Gut. 2001 Dec;49(6):783-9. doi: 10.1136/gut.49.6.783. Gut. 2001. PMID: 11709512 Free PMC article. Clinical Trial.

5

Once daily versus three times daily mesalazine granules in active ulcerative colitis: a double-blind, double-dummy, randomised, non-inferiority trial.

Kruis W, Kiudelis G, Rácz I, Gorelov IA, Pokrotnieks J, Horynski M, Batovsky M, Kykal J, Boehm S, Greinwald R, Mueller R; International Salofalk OD Study Group. Kruis W, et al. Gut. 2009 Feb;58(2):233-40. doi: 10.1136/gut.2008.154302. Epub 2008 Oct 2. Gut. 2009. PMID: 18832520 Free PMC article. Clinical Trial.

6

Double-blind dose-finding study of olsalazine versus sulphasalazine as maintenance therapy for ulcerative colitis.

Kruis W, Judmaier G, Kayasseh L, Stolte M, Theuer D, Scheurlen C, Hentschel E, Kratochvil P. Kruis W, et al. Eur J Gastroenterol Hepatol. 1995 May;7(5):391-6. Eur J Gastroenterol Hepatol. 1995. PMID: 7614099 Clinical Trial.

7

Mesalazine inhibits activation of transcription factor NF-kappaB in inflamed mucosa of patients with ulcerative colitis.

Bantel H, Berg C, Vieth M, Stolte M, Kruis W, Schulze-Osthoff K. Bantel H, et al. Among authors: kruis w. Am J Gastroenterol. 2000 Dec;95(12):3452-7. doi: 10.1111/j.1572-0241.2000.03360.x. Am J Gastroenterol. 2000. PMID: 11151876 Clinical Trial.

8

Randomised clinical trial: a comparative dose-finding study of three arms of dual release mesalazine for maintaining remission in ulcerative colitis.

Kruis W, Jonaitis L, Pokrotnieks J, Mikhailova TL, Horynski M, Bátovský M, Lozynsky YS, Zakharash Y, Rácz I, Kull K, Vcev A, Faszczyk M, Dilger K, Greinwald R, Mueller R; International Salofalk OD Study Group. Kruis W, et al. Aliment Pharmacol Ther. 2011 Feb;33(3):313-22. doi: 10.1111/j.1365-2036.2010.04537.x. Epub 2010 Dec 8. Aliment Pharmacol Ther. 2011. PMID: 21138455 Free article. Clinical Trial.

9

In vivo effects of mesalazine or E. coli Nissle 1917 on microsatellite instability in ulcerative colitis.

Goel A, Mittal A, Evstatiev R, Nemeth M, Kruis W, Stolte M, Boland CR, Gasche C. Goel A, et al. Among authors: kruis w. Aliment Pharmacol Ther. 2009 Sep 15;30(6):634-42. doi: 10.1111/j.1365-2036.2009.04076.x. Epub 2009 Jun 25. Aliment Pharmacol Ther. 2009. PMID: 19558562 Free PMC article. Clinical Trial.

10

Randomised clinical trial: mesalazine versus placebo in the prevention of diverticulitis recurrence.

Kruis W, Kardalinos V, Eisenbach T, Lukas M, Vich T, Bunganic I, Pokrotnieks J, Derova J, Kondrackiene J, Safadi R, Tuculanu D, Tulassay Z, Banai J, Curtin A, Dorofeyev AE, Zakko SF, Ferreira N, Björck S, Diez Alonso MM, Mäkelä J, Talley NJ, Dilger K, Greinwald R, Mohrbacher R, Spiller R. Kruis W, et al. Aliment Pharmacol Ther. 2017 Aug;46(3):282-291. doi: 10.1111/apt.14152. Epub 2017 May 23. Aliment Pharmacol Ther. 2017. PMID: 28543263 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

283 results

Search Page